NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free INMD Stock Alerts $17.14 +0.12 (+0.71%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$16.87▼$17.3250-Day Range$17.02▼$23.2252-Week Range$16.82▼$48.25Volume970,055 shsAverage Volume1.52 million shsMarket Capitalization$1.44 billionP/E Ratio7.45Dividend YieldN/APrice Target$32.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestSocial Media Get InMode alerts: Email Address InMode MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside91.4% Upside$32.80 Price TargetShort InterestHealthy6.58% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.58Based on 10 Articles This WeekInsider TradingN/AProj. Earnings Growth7.84%From $2.04 to $2.20 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.79 out of 5 starsMedical Sector231st out of 914 stocksElectromedical Equipment Industry5th out of 19 stocks 3.2 Analyst's Opinion Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has only been the subject of 3 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted6.58% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InMode has recently decreased by 6.43%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INMD. Previous Next 3.7 News and Social Media Coverage News SentimentInMode has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for InMode this week, compared to 7 articles on an average week.Search Interest39 people have searched for INMD on MarketBeat in the last 30 days. This is an increase of 86% compared to the previous 30 days.MarketBeat Follows10 people have added InMode to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for InMode are expected to grow by 7.84% in the coming year, from $2.04 to $2.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 7.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.71.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 7.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 236.34.Price to Book Value per Share RatioInMode has a P/B Ratio of 2.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About InMode Stock (NASDAQ:INMD)InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More INMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INMD Stock News HeadlinesApril 27, 2024 | seekingalpha.comInMode: More Headwinds Than Expected, Wait For A Floor To Materialize (Rating Downgrade)April 27, 2024 | americanbankingnews.comInMode (NASDAQ:INMD) Reaches New 52-Week Low at $16.82April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 26, 2024 | finance.yahoo.comInMode Ltd. (INMD)April 25, 2024 | americanbankingnews.comInMode (INMD) Set to Announce Earnings on ThursdayApril 20, 2024 | finance.yahoo.comInMode Ltd. (INMD) Stock Price, News, Quote & History - Yahoo FinanceApril 15, 2024 | markets.businessinsider.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InModeApril 15, 2024 | prnewswire.comINMD DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMDApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 15, 2024 | stockhouse.comFINAL INMD DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds InMode Ltd. Investors to Join the Class Action Lawsuit!April 15, 2024 | prnewswire.comShareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMDApril 15, 2024 | prnewswire.comFINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the FirmApril 13, 2024 | nasdaq.comRSI Alert: InMode (INMD) Now OversoldApril 13, 2024 | prnewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InModeApril 12, 2024 | msn.com3 Best Stocks to Buy Now, 4/12/2024, According to Top AnalystsApril 12, 2024 | prnewswire.comINMD Investors Have Opportunity to Lead InMode Ltd. Securities Fraud LawsuitApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd.- INMDApril 12, 2024 | prnewswire.comShareholders that lost money on InMode Ltd.(INMD) should contact The Gross Law Firm about pending Class Action - INMDApril 11, 2024 | stockhouse.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against InMode Ltd. (INMD)April 11, 2024 | msn.com3 Reasons I'd Consider Selling InMode’s Unusually Active Put OptionApril 11, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against InMode Ltd.April 11, 2024 | stockhouse.com4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the FirmApril 10, 2024 | prnewswire.comInMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INMDApril 9, 2024 | stockhouse.comINVESTOR DEADLINE MONDAY: InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - INMDApril 9, 2024 | msn.comInMode slips after guidance cutApril 9, 2024 | prnewswire.comInMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024April 9, 2024 | prnewswire.comInvestors in InMode Ltd. Should Contact The Gross Law Firm Before April 15, 2024 to Discuss Your Rights - INMDSee More Headlines Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/27/2024Next Earnings (Confirmed)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees581Year Founded2008Price Target and Rating Average Stock Price Target$32.80 High Stock Price Target$61.00 Low Stock Price Target$22.00 Potential Upside/Downside+91.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$2.30 Trailing P/E Ratio7.45 Forward P/E Ratio8.40 P/E GrowthN/ANet Income$197.92 million Net Margins40.22% Pretax Margin44.30% Return on Equity29.80% Return on Assets27.02% Debt Debt-to-Equity RatioN/A Current Ratio12.51 Quick Ratio11.87 Sales & Book Value Annual Sales$492.05 million Price / Sales2.93 Cash Flow$2.23 per share Price / Cash Flow7.70 Book Value$6.68 per share Price / Book2.57Miscellaneous Outstanding Shares83,980,000Free Float78,170,000Market Cap$1.44 billion OptionableOptionable Beta2.16 Social Links (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Yair Malca (Age 46)Chief Financial Officer Comp: $581kMs. Nava Tal-LaunerChief Information OfficerMr. Shakil Lakhani (Age 41)President of North America Comp: $3.49MMr. Moshe Mizrahy (Age 71)Chairman & CEO Comp: $216kMr. Alon YaariVice President of OperationsDr. Michael Kreindel (Age 56)CTO & Director Comp: $221kDr. Spero Theodorou M.D. (Age 52)Chief Medical Officer Comp: $1.84MMore ExecutivesKey CompetitorsSoleno TherapeuticsNASDAQ:SLNONatus MedicalNASDAQ:NTUSBioLife SolutionsNASDAQ:BLFSCONMEDNYSE:CNMDAxoGenNASDAQ:AXGNView All CompetitorsInstitutional OwnershipPeregrine Capital Management LLCSold 114,722 shares on 4/26/2024Ownership: 0.203%Simplex Trading LLCBought 94,700 shares on 4/25/2024Ownership: 0.000%Kercheville Advisors LLCBought 2,700 shares on 4/25/2024Ownership: 0.122%Whalen Wealth Management Inc.Bought 991 shares on 4/25/2024Ownership: 0.012%Absher Wealth Management LLCBought 2,231 shares on 4/23/2024Ownership: 0.035%View All Institutional Transactions INMD Stock Analysis - Frequently Asked Questions Should I buy or sell InMode stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" INMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INMD, but not buy additional shares or sell existing shares. View INMD analyst ratings or view top-rated stocks. What is InMode's stock price target for 2024? 6 Wall Street research analysts have issued 12-month target prices for InMode's stock. Their INMD share price targets range from $22.00 to $61.00. On average, they expect the company's share price to reach $32.80 in the next year. This suggests a possible upside of 91.4% from the stock's current price. View analysts price targets for INMD or view top-rated stocks among Wall Street analysts. How have INMD shares performed in 2024? InMode's stock was trading at $22.24 at the beginning of the year. Since then, INMD shares have decreased by 22.9% and is now trading at $17.14. View the best growth stocks for 2024 here. Are investors shorting InMode? InMode saw a decline in short interest in April. As of April 15th, there was short interest totaling 5,530,000 shares, a decline of 6.4% from the March 31st total of 5,910,000 shares. Based on an average daily volume of 1,550,000 shares, the days-to-cover ratio is currently 3.6 days. View InMode's Short Interest. When is InMode's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our INMD earnings forecast. How can I listen to InMode's earnings call? InMode will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9531570". How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) announced its quarterly earnings data on Tuesday, February, 13th. The healthcare company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.05. The healthcare company earned $126.80 million during the quarter, compared to analysts' expectations of $124.77 million. InMode had a trailing twelve-month return on equity of 29.80% and a net margin of 40.22%. InMode's quarterly revenue was down 5.1% compared to the same quarter last year. During the same period last year, the company posted $0.69 earnings per share. What ETFs hold InMode's stock? ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL), Amplify BlueStar Israel Technology ETF (ITEQ) and VanEck Israel ETF (ISRA).iShares MSCI Israel ETF (EIS). When did InMode's stock split? InMode shares split before market open on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were issued to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What guidance has InMode issued on next quarter's earnings? InMode issued an update on its FY 2024 earnings guidance on Tuesday, April, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $485.0 million-$495.0 million, compared to the consensus revenue estimate of $498.8 million. What is Moshe Mizrahy's approval rating as InMode's CEO? 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL). When did InMode IPO? InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? InMode's stock is owned by a number of institutional and retail investors. Top institutional investors include Wasatch Advisors LP (0.39%), Simplex Trading LLC (0.00%), Peregrine Capital Management LLC (0.20%), IMC Chicago LLC (0.00%), Taylor Frigon Capital Management LLC (0.13%) and Kercheville Advisors LLC (0.12%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does InMode have any subsidiaries? The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..Read More This page (NASDAQ:INMD) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.